DA
TMO icon

Dash Acquisitions’s Thermo Fisher Scientific TMO Stock Holding History

Dash Acquisitions’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Sell
28,607
-134
-0.5% -$72.7K 3.13% 10
2025
Q4 		$16.2M Sell
28,741
-806
-3% -$456K 3.39% 9
2025
Q3 		$16.5M Sell
29,547
-4,249
-13% -$1.98M 3.27% 11
2025
Q2 		$15.8M Buy
33,796
+1,844
+6% +$771K 3.34% 12
2025
Q1 		$13.7M Buy
31,952
+300
+0.9% +$162K 3.06% 12
2024
Q4 		$18.5M Buy
31,652
+751
+2% +$413K 3.94% 10
2024
Q3 		$17.1M Buy
30,901
+1,312
+4% +$777K 4.16% 11
2024
Q2 		$16.4M Buy
29,589
+2,738
+10% +$1.57M 4.49% 9
2024
Q1 		$14.7M Buy
26,851
+1,015
+4% +$570K 4.64% 9
2023
Q4 		$14.1M Buy
25,836
+878
+4% +$425K 5% 9
2023
Q3 		$12M Buy
24,958
+5,483
+28% +$2.92M 4.85% 8
2023
Q2 		$10.2M Buy
19,475
+3,207
+20% +$1.73M 4.03% 13
2023
Q1 		$9.38M Buy
16,268
+690
+4% +$389K 4.34% 11
2022
Q4 		$8.58M Buy
15,578
+9
+0.1% +$4.77K 4.51% 10
2022
Q3 		$7.9M Buy
15,569
+790
+5% +$442K 4.41% 11
2022
Q2 		$8.03M Buy
14,779
+75
+0.5% +$41.3K 4.39% 10
2022
Q1 		$8.69M Buy
14,704
+589
+4% +$338K 3.93% 13
2021
Q4 		$9.42M Buy
14,115
+931
+7% +$581K 4.08% 11
2021
Q3 		$7.53M Buy
13,184
+1,131
+9% +$621K 3.92% 13
2021
Q2 		$6.08M Buy
12,053
+855
+8% +$403K 3.46% 13
2021
Q1 		$5.11M Buy
11,198
+8,315
+288% +$3.97M 3.36% 13
2020
Q4 		$1.34M Buy
+2,883
New +$1.35M 0.94% 22

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dash Acquisitions's TMO Position: Q1 2026 in Review

Dash Acquisitions reduced its Thermo Fisher Scientific (TMO) stake by 0.47% in Q1 2026, selling an estimated $72.7K and leaving 28,607 shares worth $15M. The position accounts for 3.13% of the portfolio, ranked #10.

Dash Acquisitions first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $18.5M in Q4 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Dash Acquisitions held 28,607 shares of Thermo Fisher Scientific worth $15M as of Q1 2026.
  • Dash Acquisitions sold 134 Thermo Fisher Scientific shares in Q1 2026, an estimated $72.7K.
  • Thermo Fisher Scientific made up 3.13% of Dash Acquisitions's portfolio in Q1 2026, its #10 holding.
  • Dash Acquisitions first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • Dash Acquisitions's Thermo Fisher Scientific position peaked at $18.5M in Q4 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Dash Acquisitions's 13F filing for Q1 2026, filed 8 May 2026.